Quantcast
Viewing all articles
Browse latest Browse all 1030

CheckedUp and TearScience® Team Up to Impact Dry Eye Patient Education

Saturday, May 6th 2017 at 12:00pm UTC

– Partnership brings CheckedUp Platform to hundreds of clinics
nationwide –

NEW YORK–(BUSINESS WIRE)– CheckedUp, a specialty point of care company, today announced a
nationwide partnership with TearScience®, the maker of Lipiflow®, to
introduce the CheckedUp Engagement Platform to TearScience customers.
The CheckedUp platform engages patients at each stage in the
decision-making process and is proven to increase patients understanding
of their disease and confidence in their treatment options.
Demonstrations of the Platform will be available at the CheckedUp
exhibit booth (#615) during the American Society of Cataract and
Refractive Surgery (ASCRS) in Los Angeles, California, May 4-8, 2017.

This Smart News Release features multimedia. View the full release here:
http://www.businesswire.com/news/home/20170506005013/en/

Image may be NSFW.
Clik here to view.
CheckedUp Explorer features engaging full-motion HD video programming and a customizable side bar th ...

CheckedUp Explorer features engaging full-motion HD video programming and a customizable side bar that rotates from practice information and marketing to patient questions (Photo: Business Wire)

“By providing the entry point to a digital, multi-channel educational
environment, this partnership provides real value to ophthalmic
practices that want to help their patients make more informed choices
about treating their dry eye disease, particularly premium treatment
options,” said Richard Awdeh, M.D., CEO and Founder of CheckedUp. “The
TearScience team saw that the CheckedUp Platform offered a way to
address the information needs of the patient within the highly
time-constrained practice setting around a disease and treatment options
in a therapeutic are that has become more complex.”

“Patients participate in their own care more effectively when they’ve
had a chance to learn about their options, but time and staff
limitations make it challenging to provide education in a busy
practice,” said Tom Chirillo, senior vice president, Sales and
Marketing, TearScience. “CheckedUp Explorer will allow each practice to
shape the information presented about management of meibomian gland
disease and chronic dry eye to encourage patient self-selection and
discussion in ways that fit the physician’s preferences. It is both
customized and turn-key – the patient wins and the practice wins.”

Under the agreement, TearScience representatives will provide the
CheckedUp Explorer waiting room package to their customers as the first
component of the full CheckedUp Platform. The Explorer package includes
a 43” flat panel TV, engaging full-motion HD video programming that is
updated monthly, a customizable side bar that rotates from practice
information and marketing to patient questions, and lifetime system
maintenance.

“Our practice sees hundreds of dry eye patients every year and I
understand first-hand the challenges of explaining and reviewing all of
the treatment options,” said Elizabeth Yeu, M.D., Virginia Eye
Consultants. “As a TearScience customer, I am thrilled that I can now
offer CheckedUp dry eye education to my patients, which will save my
staff time and create a better overall patient experience.”

The CheckedUp Platform

Reaching the patient from home to the doctor’s office and back, while
enhancing office staff’s ability to improve productivity and drive
revenue growth, the comprehensive CheckedUp Patient Engagement Platform
includes four additional components that, together with CheckedUp
Explorer, provide several hours of targeted, practice-curated content at
the point of interest or at the point of care.

  • CheckedUp Engage: Interactive kiosks with in-depth education
    modules on all key eye-health categories, including condition
    information, treatment options and health assessments, that
    seamlessly extends the patient education from the waiting room to the
    exam room.
  • CheckedUp Consult: The 26-inch wallboard delivers clear and
    accurate interactive content in the exam room to help physicians and
    patients make health decisions together. Offers in-depth views of
    conditions and treatments that physicians can annotate in real-time
    and instantly email directly to patients. Patients gain clarity
    through an extensive library of disease and treatment information and
    3-D anatomical renderings.
  • CheckedUp Reach: Enhances the patient experience by providing
    instant access to disease education, treatment options and tailored
    content from the comfort of home on the patient’s mobile device or
    computer.
  • CheckedUp Manage: The analytics dashboard tracks and highlights
    patient preferences for easy access by staff and physicians.
    Delivering real-time patient progress updates leading to proactive
    consultations and practice optimization and analyzing practice
    conversion rates and overall performance continually leading to higher
    practice productivity.

About TearScience®

TearScience, a medical device company, has pioneered technologies and
leads innovation to vastly improve evaluation of meibomian glands and
treatment of meibomian gland dysfunction (MGD). A progressive,
obstructive disease and root cause of Dry Eye, MGD is distinguished by
loss of function and structure of tear oil (meibomian) glands. MGD
affects approximately 86% of the millions of Dry Eye sufferers worldwide
and is highly prevalent in the general ophthalmic population. LipiView
II and new LipiScan with Dynamic Meibomian Imaging™ (DMI) distinctively
image meibomian gland structure. The Korb Meibomian Gland Evaluator™
assists physicians to reproducibly assess gland function. LipiFlow uses
Vectored Thermal Pulse™ (VTP) technology to precisely direct treatment
from the inner-lid and has received clearance by the US Food and Drug
Administration for use in patients with MGD. Sponsored and unsponsored
multicenter, randomized, controlled clinical studies of LipiFlow
demonstrate its safety and sustained effectiveness. For additional
information on how TearScience improves meibomian gland function, and
symptoms for patients with MGD worldwide, visit www.TearScience.com.

About CheckedUp

CheckedUp is a premier specialty point of care platform that actively
engages patients before, during and after visiting the practice leading
to higher premium procedure selections, better educated and more
confident patients and time savings for the practice. More information
is available at www.checkedup.com.

Image may be NSFW.
Clik here to view.

Contacts

CheckedUp
Jennifer Mons, 904-343-3449 (cell)
jenna@getcheckedup.com
or
Media
BioComm
Network, Inc.
Tad Heitmann, 714-273-2937 (cell)
theitmann@biocommnetwork.com

Source: CheckedUp

Cet article CheckedUp and TearScience® Team Up to Impact Dry Eye Patient Education est apparu en premier sur EEI-BIOTECHFINANCES.


Viewing all articles
Browse latest Browse all 1030

Trending Articles